Arrowhead Pharmaceuticals(ARWR) - 2025 Q2 - Earnings Call Transcript

Arrowhead Pharmaceuticals (ARWR) Q2 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Vincent Anzalone - Vice President, Investor RelationsChristopher Anzalone - President, CEO & Chairman of BoardBruce Given - Chief Medical ScientistAndy Davis - SVP of Cardiovascular & Head of Metabolic FranchiseDr. James Hamilton - Chief Medical OfficerKen Myszkowski - CFOPatrick Trucchio - Managing DirectorAndrea Newkirk - Biotechnolgy Equity ResearchMichael Ulz - Executive DirectorMayank Mamtani - Senior M ...